Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed, S. H., Kenny, P. J., Koob, G. F., & Markou, A. (2002). Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nature Neuroscience, 5(7), 625–626.
al'Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004). Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug and Alcohol Dependence, 73(3), 267–278.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Press.
Arnold, J. M., & Roberts, D. C. S. (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacology Biochemistry and Behavior, 57(3), 441–447.
Baldwin, H. A., & Koob, G. F. (1993). Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology, 8(1), 15–21.
Balfour, D. J., Wright, A. E., Benwell, M. E., & Birrell, C. E. (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioural Brain Research, 113(1–2), 73–83.
Bardo, M. T., Green, T. A., Crooks, P. A., & Dwoskin, L. P. (1999). Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl), 146(3), 290–296.
Benowitz, N. L., & Jacob, P., 3rd. (1984). Daily intake of nicotine during cigarette smoking. Clinical Pharmacology and Therapeutics, 35(4), 499–504.
Bozarth, M. A., Pudiak, C. M., & KuoLee, R. (1998). Effect of chronic nicotine on brain stimulation reward. II. An escalating dose regimen. Behavioural Brain Research, 96(1–2), 189–194.
Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2007). Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology, 32(4), 955–963.
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., et al. (2002). Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology (Berl), 163(2), 230–237.
Caine, S. B., & Koob, G. F. (1995). Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behavioural Pharmacology, 6(4), 333–347.
Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000). Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug and Alcohol Dependence, 58(1–2), 93–102.
Centers for Disease Control and Prevention (2005). Cigarette smoking among adults--United States, 2004. Morbidity and Mortality Weekly Report, 54(44), 1121–1124.
Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006). Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl), 184(3–4), 353–366.
Chiamulera, C., Borgo, C., Falchetto, S., Valerio, E., & Tessari, M. (1996). Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology (Berl), 127(2), 102–107.
Corrigall, W. A. (1999). Nicotine self-administration in animals as a dependence model. Nicotine and Tobacco Research, 1(1), 11–20.
Corrigall, W. A., & Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl), 99(4), 473–478.
Crooks, P. A., & Dwoskin, L. P. (1997). Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochemical Pharmacology, 54(7), 743–753.
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003). Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl), 168(3), 347–358.
Damaj, M. I., Kao, W., & Martin, B. R. (2003). Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. Journal of Pharmacology and Experimental Therapeutics, 307(2), 526–534.
DeNoble, V. J., & Mele, P. C. (2006). Intravenous nicotine self-administration in rats: Effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology (Berl), 184(3–4), 266–272.
Depoortere, R. Y., Li, D. H., Lane, J. D., & Emmett-Oglesby, M. W. (1993). Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacology Biochemistry and Behavior, 45(3), 539–548.
Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavioural Brain Research, 137(1–2), 75–114.
Donny, E. C., Caggiula, A. R., Knopf, S., & Brown, C. (1995). Nicotine self-administration in rats. Psychopharmacology (Berl), 122(4), 390–394.
Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., et al. (1999). Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl), 147(2), 135–142.
Dwoskin, L. P., Teng, L., Buxton, S. T., & Crooks, P. A. (1999). (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner. Journal of Pharmacology and Experimental Therapeutics, 288(3), 905–911.
Engberg, G., & Hajos, M. (1994). Nicotine-induced activation of locus coeruleus neurons: an analysis of peripheral versus central induction. Naunyn Schmiedeberg's Archives of Pharmacology, 349(5), 443–446.
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature, 393(6680), 76–79.
Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. Journal of the American Medical Association, 271(24), 1940–1947.
Geyer, M. A., & Markou, A. (1995). Animal models of psychiatric disorders. In: Psychopharmacology: The Fourth Generation of Progress.: Raven Press New York, NY. pp 787–798.
Glassman, A. H., Helzer, J. E., Covey, L. S., Cottler, L. B., Stetner, F., Tipp, J. E., et al. (1990). Smoking, smoking cessation, and major depression. Journal of the American Medical Association, 264(12), 1546–1549.
Goldberg, S. R., & Schuster, C. R. (1967). Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. Journal of the Experimental Analysis of Behavior, 10(3), 235–242.
Goldberg, S. R., Spealman, R. D., & Goldberg, D. M. (1981). Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science, 214(4520), 573–575.
Gosling, J. A., & Lu, T. C. (1969). Uptake and distribution of some quaternary ammonium compounds in the central nervous system of the rat. Journal of Pharmacology and Experimental Therapeutics, 167(1), 56–62.
Grottick, A. J., & Higgins, G. A. (2000). Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behavioural Brain Research, 117(1–2), 197–208.
Harrison, A. A., Gasparini, F., & Markou, A. (2002). Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl), 160(1), 56–66.
Harrison, A. A., Liem, Y. T., & Markou, A. (2001). Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology, 25(1), 55–71.
Hellemans, K. G., Dickinson, A., & Everitt, B. J. (2006). Motivational control of heroin seeking by conditioned stimuli associated with withdrawal and heroin taking by rats. Behavioral Neuroscience, 120(1), 103–114.
Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997). Behavioral manifestations of the nicotine abstinence syndrome in the rat: Peripheral versus central mechanisms. Psychopharmacology (Berl), 129(4), 348–356.
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilstrom, B., & Svensson, T. H. (1998). Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Research, 779(1–2), 214–225.
Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43(3), 289–294.
Hutcheson, D. M., Everitt, B. J., Robbins, T. W., & Dickinson, A. (2001). The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nature Neuroscience, 4(9), 943–947.
Irvine, E. E., Cheeta, S., & File, S. E. (2001). Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacology Biochemistry and Behavior, 68(2), 319–325.
Jones, G. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl), 108(4), 485–494.
Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A., & Koob, G. F. (2006). Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. Journal of Neuroscience, 26(22), 5894–5900.
Kenny, P. J., Gasparini, F., & Markou, A. (2003). Group II metabotropic and α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Journal of Pharmacology and Experimental Therapeutics, 306(3), 1068–1076.
Kenny, P. J., Koob, G. F., & Markou, A. (2003). Conditioned facilitation of brain reward function after repeated cocaine administration. Behavioral Neuroscience, 117(5), 1103–1107.
Kenny, P. J., & Markou, A. (2001). Neurobiology of the nicotine withdrawal syndrome. Pharmacology Biochemistry and Behavior, 70(4), 531–549.
Kenny, P. J., & Markou, A. (2005). Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. Journal of Neuroscience, 25(26), 6208–6212.
Kenny, P. J., & Markou, A. (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31(6), 1203–1211.
Koob, G. F., & Le Moal, M. (2005). Neurobiology of Addiction. London: Academic Press.
LeSage, M. G., Burroughs, D., Dufek, M., Keyler, D. E., & Pentel, P. R. (2004). Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacology Biochemistry and Behavior, 79(3), 507–513.
LeSage, M. G., Keyler, D. E., Shoeman, D., Raphael, D., Collins, G., & Pentel, P. R. (2002). Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacology Biochemistry and Behavior, 72(1–2), 279–289.
Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J., et al. (1998). Transdermal nicotine effects on attention. Psychopharmacology (Berl), 140(2), 135–141.
Levin, E. D., & Rezvani, A. H. (2002). Nicotinic treatment for cognitive dysfunction. Current Drug Targets. CNS and Neurological Disorders, 1(4), 423–431.
Levin, E. D., & Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl), 138(3–4), 217–230.
Lindblom, N., de Villiers, S. H., Semenova, S., Kalayanov, G., Gordon, S., Schilstrom, B., et al. (2005). Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs. Naunyn-Schmiedeberg's Archives of Pharmacology, 372(3), 182–194.
Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Poland, R. E., & Pechnick, R. N. (2006). Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. Psychopharmacology (Berl), 184(3–4), 417–425.
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., Hebert, K. M., Conrad, D. L., et al. (1994). The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl), 115(1–2), 180–184.
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., et al. (1992). Rodent model of nicotine abstinence syndrome. Pharmacology Biochemistry and Behavior, 43(3), 779–784.
Malin, D. H., Lake, J. R., Payne, M. C., Short, P. E., Carter, V. A., Cunningham, J. S., et al. (1996). Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacology Biochemistry and Behavior, 53(1), 81–85.
Malin, D. H., Lake, J. R., Schopen, C. K., Kirk, J. W., Sailer, E. E., Lawless, B. A., et al. (1997). Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium. Pharmacology Biochemistry and Behavior, 58(3), 695–699.
Markou, A., & Kenny, P. J. (2002). Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotoxicology Research, 4(4), 297–313.
Markou, A., & Koob, G. F. (1991). Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology, 4(1), 17–26.
Markou, A., & Koob, G. F. (1992). Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiology and Behavior, 51(1), 111–119.
Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology, 18(3), 135–174.
Markou, A., & Paterson, N. E. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine and Tobacco Research, 3(4), 361–373.
Markou, A., Weiss, F., Gold, L. H., Caine, S. B., Schulteis, G., & Koob, G. F. (1993). Animal models of drug craving. Psychopharmacology (Berl), 112(2–3), 163–182.
McGregor, A., & Roberts, D. C. S. (1995). Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behavioural Brain Research, 67(1), 75–80.
Mirza, N. R., & Stolerman, I. P. (1998). Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl), 138(3–4), 266–274.
Murrin, L. C., Ferrer, J. R., Zeng, W. Y., & Haley, N. J. (1987). Nicotine administration to rats: Methodological considerations. Life Sciences, 40(17), 1699–1708.
O'Brien, C. P., Testa, T., O'Brien, T. J., Brady, J. P., & Wells, B. (1977). Conditioned narcotic withdrawal in humans. Science, 195(4282), 1000–1002.
Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419–427.
Parrott, A. C. (1993). Cigarette smoking: effects upon self-rated stress and arousal over the day. Addictive Behaviors, 18(4), 389–395.
Paterson, N. E., Balfour, D. J., & Markou, A. (2007). Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. European Journal of Neuroscience, 25(10), 3099–3108.
Paterson, N. E., Bruijnzeel, A. W., Kenny, P. J., Wright, C. D., Froestl, W., & Markou, A. (2005). Prolonged nicotine exposure does not alter GABAB receptor-mediated regulation of brain reward function. Neuropharmacology, 49(7), 953–962.
Paterson, N. E., Froestl, W., & Markou, A. (2004). The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl), 172(2), 179–186.
Paterson, N. E., Froestl, W., & Markou, A. (2005). Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology, 30(1), 119–128.
Paterson, N. E., & Markou, A. (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport, 14(17), 2229–2232.
Paterson, N. E., & Markou, A. (2004). Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl), 173(1–2), 64–72.
Paterson, N. E., Myers, C., & Markou, A. (2000). Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl), 152(4), 440–446.
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003). Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. Journal of Abnormal Psychology, 112(1), 14–27.
Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., et al. (1998). Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173–177.
Pickens, R., & Thompson, T. (1968). Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. Journal of Pharmacology and Experimental Therapeutics, 161(1), 122–129.
Risner, M. E., & Goldberg, S. R. (1983). A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. Journal of Pharmacology and Experimental Therapeutics, 224(2), 319–326.
Rose, J. E. (2006). Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl), 184(3–4), 274–285.
Rowlett, J. K. (2000). A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology (Berl), 153(1), 1–16.
Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., et al. (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry, 62(6), 649–659.
Sannerud, C. A., Prada, J., Goldberg, D. M., & Goldberg, S. R. (1994). The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. European Journal of Pharmacology, 271(2–3), 461–469.
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995). Decreased brain reward produced by ethanol withdrawal. Proceedings of the National Academy of Sciences of the United States of America, 92(13), 5880–5884.
Schulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994). Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis. Journal of Pharmacology and Experimental Therapeutics, 271(3), 1391–1398.
See, R. E., Grimm, J. W., Kruzich, P. J., & Rustay, N. (1999). The importance of a compound stimulus in conditioned drug-seeking behavior following one week of extinction from self-administered cocaine in rats. Drug and Alcohol Dependence, 57(1), 41–49.
Semenova, S., & Markou, A. (2003). Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Biological Psychiatry, 54(11), 1249–1264.
Semenova, S., Stolerman, I. P., & Markou, A. (2007). Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacology Biochemistry and Behavior, 87(3), 360–368.
Shaham, Y., Adamson, L. K., Grocki, S., & Corrigall, W. A. (1997). Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology (Berl), 130(4), 396–403.
Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. (2003). The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology (Berl), 168(1–2), 3–20.
Shoaib, M., & Bizarro, L. (2005). Deficits in a sustained attention task following nicotine withdrawal in rats. Psychopharmacology (Berl), 178(2–3), 211–222.
Shoaib, M., & Stolerman, I. P. (1999). Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology (Berl), 143(3), 318–321.
Skjei, K. L., & Markou, A. (2003). Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology (Berl), 168(3), 280–292.
Smolka, M. N., Budde, H., Karow, A. C., & Schmidt, L. G. (2004). Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence. Psychopharmacology (Berl), 175(3), 374–381.
Snyder, F. R., & Henningfield, J. E. (1989). Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl), 97(1), 17–22.
Spielewoy, C., & Markou, A. (2003). Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function. Neuropsychopharmacology, 28(6), 1106–1116.
Stolerman, I. P., & Jarvis, M. J. (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl), 117(1), 2–10; discussion 14–20.
Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. (1996). Mecamylamine-precipitated nicotine-withdrawal aversion in rats. European Journal of Pharmacology, 314(3), 281–284.
Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl), 84(3), 405–412.
Valentine, J. D., Hokanson, J. S., Matta, S. G., & Sharp, B. M. (1997). Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl), 133(3), 300–304.
Watkins, S. S., Epping-Jordan, M. P., Koob, G. F., & Markou, A. (1999). Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacology Biochemistry and Behavior, 62(4), 743–751.
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000). Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects. Journal of Pharmacology and Experimental Therapeutics, 292(3), 1053–1064.
West, R. J., Jarvis, M. J., Russell, M. A., Carruthers, M. E., & Feyerabend, C. (1984). Effect of nicotine replacement on the cigarette withdrawal syndrome. British Journal of Addiction, 79(2), 215–219.
Acknowledgements
AM was supported by Research Grant 15RT-0022 from the Tobacco-Related Disease Research Program of the State of California, and NIH grants U01 MH69062, R01 DA11946 and R01 DA023209. NEP was supported by postdoctoral fellowship 14FT-0056 from the Tobacco-Related Disease Research Program of the State of California and the Peter F. McManus Charitable Trust. The authors would like to thank Mr. Michael Arends for editorial assistance, and Ms. Janet Hightower for graphics. Finally, the authors would like to thank Drs. John Cryan, Adrie Bruijnzeel, Mark Epping-Jordan, Amanda Harrison, Paul Kenny, Svetlana Semenova, Cecile Spielewoy, Serge Ahmed and Shelly Watkins for their great experimental and intellectual contribution to this research program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Markou, A., Paterson, N.E. (2008). Multiple Motivational Forces Contribute to Nicotine Dependence. In: Caggiula, A., Bevins, R. (eds) The Motivational Impact of Nicotine and its Role in Tobacco Use. Nebraska Symposium on Motivation, vol 55. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78748-0_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-78748-0_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78748-0
Online ISBN: 978-0-387-78749-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)